Redefining breast cancer: therapeutic opportunities in HER2-low and emerging molecular subtypes.
Saved in:
| Title: | Redefining breast cancer: therapeutic opportunities in HER2-low and emerging molecular subtypes. |
|---|---|
| Authors: | Shadab A; Faculty of Pharmacy, Integral University, Lucknow, 226026, India. abshadab@student.iul.ac.in., Al-Shdefat RIK; Faculty of Pharmacy, Jadara University, Irbid, Jordan. |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Jul 21. Date of Electronic Publication: 2026 Jul 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
